The GLYCART Scientific Advisory Board
Professor Martin J.S. Dyer, MA DPhil FRCP FRCPath is Professor of Haemato-Oncology at the University of Leicester and Warwick Medical School, UK, and Honorary Consultant Physician at the MRC Toxicology Unit. Professor Dyer is recognized worldwide as a leading authority in the field of antibody therapy of hematological malignancies.
Georges Haas, PhD received a doctorate in chemistry from ETH (Zurich) and international management training at Harvard University. His 27-year career in R&D management at Ciba-Geigy culminated as head of Pharma Research and Preclinical Development worldwide. He holds many patents in the field of pharmaceuticals. Since retiring in 1997, he has been serving as director of GLSV Partners Holding AG (Zug), and as a business advisor to numerous start-up companies in Europe and USA.
Professor Sibrand Poppema, MD, Ph.D., FRCPC is Dean of the Faculty of Medical Sciences and Member of the Board of Directors of the University Medical Center, Groningen. Professor Poppema is recognized worldwide as a leading authority in immunological and genetic research in the field of lymphoma.
Louis M. Weiner, MD is Vice President, Translational Research, and Chairman, Department of Medical Oncology at Fox Chase Cancer Center, where he holds the G. Morris Dorrance Jr. Endowed Chair in Medical Science. Dr. Weiner’s research centers on the use of antibody-based molecules to target tumors, with an emphasis on understanding the principles of tumor targeting and the use of antibodies to initiate host immune-mediated tumor lysis.
He has been at the forefront of efforts to develop antibody-based therapies of human cancer, and has been a pioneer in the use of antibody engineering to improve selective tumor targeting and to manipulate antibody-directed immune effector functions. Dr. Weiner received his MD from Mount Sinai School of Medicine in 1977 and his BA with Honors in Biology from the University of Pennsylvania in 1973.
He is Chair of an American Association of Cancer Research (AACR) task force on Immunology. Dr. Weiner was the recipient of the 2001 American Cancer Society Southeast Region Research Award.